Published in BMC Med Ethics on February 03, 2014
Individualized medicine enabled by genomics in Saudi Arabia. BMC Med Genomics (2015) 0.87
The risk of re-identification versus the need to identify individuals in rare disease research. Eur J Hum Genet (2016) 0.78
Genes, cells, and biobanks: Yes, there's still a consent problem. PLoS Biol (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet (2008) 20.38
International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics (2002) 12.36
Identifying personal genomes by surname inference. Science (2013) 10.79
Ethics. Identifiability in genomic research. Science (2007) 9.08
Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc (2006) 7.77
Genetics. Genomic research and human subject privacy. Science (2004) 6.56
Genetics. No longer de-identified. Science (2006) 6.20
From genetic privacy to open consent. Nat Rev Genet (2008) 5.95
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Human oocytes reprogram somatic cells to a pluripotent state. Nature (2011) 4.03
Research ethics. The complexities of genomic identifiability. Science (2013) 3.23
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Towards a data sharing Code of Conduct for international genomic research. Genome Med (2011) 2.98
A systematic review of re-identification attacks on health data. PLoS One (2011) 2.91
Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96
Broadening consent--and diluting ethics? J Med Ethics (2009) 1.87
Genomic databases access agreements: legal validity and possible sanctions. Hum Genet (2011) 1.72
Biobanks, consent and claims of consensus. Nat Methods (2012) 1.66
Identifiability in biobanks: models, measures, and mitigation strategies. Hum Genet (2011) 1.66
Assessing and managing risk when sharing aggregate genetic variant data. Nat Rev Genet (2011) 1.62
Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol (2009) 1.58
Re-identification of familial database records. AMIA Annu Symp Proc (2006) 1.56
Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med (2013) 1.55
Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). PLoS Comput Biol (2012) 1.55
Public opinion and trust in scientists: the role of the research context, and the perceived motivation of stem cell researchers. Public Underst Sci (2008) 1.40
Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur J Hum Genet (2005) 1.40
Tissue donation to biobanks: a review of sociological studies. Sociol Health Illn (2011) 1.32
The stem cell research environment: a patchwork of patchworks. Stem Cell Rev (2009) 1.21
iPS cells: mapping the policy issues. Cell (2009) 1.11
Disclosure and management of research findings in stem cell research and banking: policy statement. Regen Med (2012) 1.10
Cancer patient perceptions on the ethical and legal issues related to biobanking. BMC Med Genomics (2013) 1.08
Canadian governance of health research involving human subjects: is anybody minding the store? Health Law J (2001) 1.02
Stem cell research ethics: consensus statement on emerging issues. J Obstet Gynaecol Can (2007) 1.02
Trustworthy reuse of health data: a transnational perspective. Int J Med Inform (2012) 1.01
Data re-identification: societal safeguards. Science (2013) 0.99
How anonymous is 'anonymous'? Some suggestions towards a coherent universal coding system for genetic samples. J Med Ethics (2012) 0.94
From banking to international governance: fostering innovation in stem cell research. Stem Cells Int (2011) 0.93
NCI think tank concerning the identifiability of biospecimens and "omic" data. Genet Med (2013) 0.92
Informed consent in embryonic stem cell research: are we following basic principles? CMAJ (2007) 0.87
OECD guidelines on human biobanks and genetic research databases. Eur J Health Law (2010) 0.87
International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006). Med Law (2008) 0.86
Policy interoperability in stem cell research: demystifying harmonization. Stem Cell Rev (2009) 0.84
Genetic information and life insurance: a 'real' risk? Eur J Hum Genet (2003) 0.82
Caught you: threats to confidentiality due to the public release of large-scale genetic data sets. BMC Med Ethics (2010) 0.81
Withdrawal from biobank research: considerations and the way forward. Stem Cell Rev (2012) 0.80
Stem cells: will they ever be the same? Regen Med (2013) 0.76
Genomic data disclosure: time to reassess the realities. Am J Bioeth (2013) 0.76
The governance of research involving human participants in Canada. Health Law J (2003) 0.76
International network of cancer genome projects. Nature (2010) 20.35
The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth (2004) 14.06
Prepublication data sharing. Nature (2009) 12.24
Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioeth (2008) 5.73
Dealing with the long-term social implications of research. Am J Bioeth (2011) 5.41
The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet (2006) 5.34
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg (2010) 5.05
Medical and nursing students' television viewing habits: potential implications for bioethics. Am J Bioeth (2008) 4.94
Stem cell tourism and doctors' duties to minors--a view from Canada. Am J Bioeth (2010) 4.93
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet (2008) 4.03
Who's using PDAs? Estimates of PDA use by health care providers: a systematic review of surveys. J Med Internet Res (2006) 3.73
The auxin influx carrier LAX3 promotes lateral root emergence. Nat Cell Biol (2008) 3.69
Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med (2004) 3.58
Evaluating re-identification risks with respect to the HIPAA privacy rule. J Am Med Inform Assoc (2010) 3.48
Ethical goals of community consultation in research. Am J Public Health (2005) 3.46
Medicine. The future of personal genomics. Science (2007) 3.36
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Bioethics consultation in the private sector. Hastings Cent Rep (2002) 3.01
A systematic review of re-identification attacks on health data. PLoS One (2011) 2.91
Point-counterpoint. Ethics and genomic incidental findings. Science (2013) 2.73
The inescapable relevance of bioethics for the practicing clinician. Chest (2006) 2.70
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med (2003) 2.56
Ethical considerations for short-term experiences by trainees in global health. JAMA (2008) 2.48
The disclosure of diagnosis codes can breach research participants' privacy. J Am Med Inform Assoc (2010) 2.45
Science and regulation. Regulating direct-to-consumer personal genome testing. Science (2010) 2.40
Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol (2003) 2.38
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell (2008) 2.35
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood (2009) 2.31
The MITRE Identification Scrubber Toolkit: design, training, and assessment. Int J Med Inform (2010) 2.29
Hip pain and heart failure: the missing link. Can J Cardiol (2013) 2.26
Anonymization of electronic medical records for validating genome-wide association studies. Proc Natl Acad Sci U S A (2010) 2.24
Genomics. Deflating the genomic bubble. Science (2011) 2.20
Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ (2008) 2.19
Personal medicine--the new banking crisis. Nat Biotechnol (2012) 2.09
Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial. Can J Cardiol (2012) 2.02
Science communication reconsidered. Nat Biotechnol (2009) 2.02
The Presidential Bioethics Commission's database of human subjects research. IRB (2013) 1.98
Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings? Clin Infect Dis (2013) 1.92
Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum (2003) 1.86
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies. Blood (2009) 1.78
Clockwork Orange is a transcriptional repressor and a new Drosophila circadian pacemaker component. Genes Dev (2007) 1.73
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest (2013) 1.72
A cryptographic approach to securely share and query genomic sequences. IEEE Trans Inf Technol Biomed (2008) 1.71
Ethics in human subjects research: do incentives matter? J Med Philos (2004) 1.70
Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells (2008) 1.69
Measuring trust in medical researchers. Med Care (2006) 1.69
Open science versus commercialization: a modern research conflict? Genome Med (2012) 1.69
Biobanks, consent and claims of consensus. Nat Methods (2012) 1.66
Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol (2002) 1.64
What patients say about medical research. IRB (1999) 1.63
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med (2006) 1.63
Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med (2005) 1.62
Back to the rough ground: working in international HIV prevention as ethical debates continue. IRB (2003) 1.62
Estimating the re-identification risk of clinical data sets. BMC Med Inform Decis Mak (2012) 1.61
No association between telomere length and blood cell counts in elderly individuals. J Gerontol A Biol Sci Med Sci (2009) 1.61
Is there a human homologue to the murine proteolysis-inducing factor? Clin Cancer Res (2007) 1.59
Physicians, genetics and life insurance. CMAJ (2004) 1.57
Permission and assent for clinical research in pediatric anesthesia. Anesth Analg (2002) 1.56
Race and ancestry in biomedical research: exploring the challenges. Genome Med (2009) 1.55
Ethical and practical issues associated with aggregating databases. PLoS Med (2008) 1.53
Community hospital oversight of clinical investigators' financial relationships. IRB (2009) 1.51
Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research. Circ Cardiovasc Qual Outcomes (2010) 1.50
Applying justice in clinical trials for diverse populations. Clin Trials (2007) 1.46
Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med (2006) 1.43
Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest (2005) 1.43
Unraveling the evolution of auxin signaling. Plant Physiol (2010) 1.41
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med (2007) 1.40
No decrease in incidence of atrial fibrillation in patients undergoing off-pump coronary artery bypass grafting. Heart Lung Circ (2002) 1.38
Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy. Coron Artery Dis (2016) 1.38
Implications of universal screening for HIV infection. BMJ (2013) 1.37
Myocyte growth, repair, and oxidative stress following pediatric heart transplantation. Pediatr Transplant (2014) 1.37
A community assessment of privacy preserving techniques for human genomes. BMC Med Inform Decis Mak (2014) 1.37
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol (2013) 1.33
The Bio-PIN: a concept to improve biobanking. Nat Rev Cancer (2011) 1.32
Beyond "compliance": the role of institutional culture in promoting research integrity. Acad Med (2010) 1.30
Preventive misconception: its nature, presence, and ethical implications for research. Am J Prev Med (2007) 1.30
Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey. Fertil Steril (2008) 1.30
Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries. BMC Med Ethics (2010) 1.28
Beyond Safe Harbor: Automatic Discovery of Health Information De-identification Policy Alternatives. IHI (2010) 1.27
The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider. Stem Cells Transl Med (2013) 1.26
Regulatory challenges for the resuscitation outcomes consortium. Circulation (2008) 1.26
Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci U S A (2004) 1.25
Variability in the costs of institutional review board oversight. Acad Med (2006) 1.25
"Not all my friends need to know": a qualitative study of teenage patients, privacy, and social media. J Am Med Inform Assoc (2012) 1.24
Toward protecting the safety of participants in clinical trials. Control Clin Trials (2003) 1.23
Effects of disclosing financial interests on attitudes toward clinical research. J Gen Intern Med (2008) 1.23
Improving informed consent: the medium is not the message. IRB (2004) 1.23
Stem cell clinics in the news. Nat Biotechnol (2010) 1.22
Controversy and quality improvement: lingering questions about ethics, oversight, and patient safety research. Jt Comm J Qual Patient Saf (2008) 1.22